pharmaceutical investing Dova Pharmaceuticals Announces European Union Marketing Authorization for DOPTELET®
pharmaceutical investing Dova Pharmaceuticals and Salix Enter Into Exclusive Co-Promotion Agreement For DOPTELET (Avatrombopag)
US Capital Global Facilitates $50MM Financing to Accelerate Charbone Hydrogen's North American Expansion
